U.S Physical Therapy ROE 2010-2023 | USPH

Current and historical return on equity (ROE) values for U.S Physical Therapy (USPH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
U.S Physical Therapy ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.03B $0.48B 6.29%
2023-09-30 $0.03B $0.49B 7.41%
2023-06-30 $0.03B $0.49B 8.58%
2023-03-31 $0.03B $0.32B 9.81%
2022-12-31 $0.03B $0.32B 10.59%
2022-09-30 $0.04B $0.32B 13.04%
2022-06-30 $0.04B $0.31B 13.34%
2022-03-31 $0.04B $0.30B 13.96%
2021-12-31 $0.04B $0.30B 13.91%
2021-09-30 $0.04B $0.29B 15.21%
2021-06-30 $0.04B $0.29B 15.91%
2021-03-31 $0.04B $0.28B 15.58%
2020-12-31 $0.04B $0.28B 13.42%
2020-09-30 $0.03B $0.27B 11.92%
2020-06-30 $0.03B $0.26B 11.45%
2020-03-31 $0.03B $0.24B 13.87%
2019-12-31 $0.04B $0.24B 17.19%
2019-09-30 $0.04B $0.24B 18.54%
2019-06-30 $0.04B $0.23B 18.59%
2019-03-31 $0.04B $0.22B 16.20%
2018-12-31 $0.03B $0.22B 15.98%
2018-09-30 $0.03B $0.21B 14.76%
2018-06-30 $0.03B $0.21B 13.54%
2018-03-31 $0.02B $0.21B 11.85%
2017-12-31 $0.02B $0.21B 11.07%
2017-09-30 $0.02B $0.20B 10.28%
2017-06-30 $0.02B $0.20B 10.04%
2017-03-31 $0.02B $0.19B 10.31%
2016-12-31 $0.02B $0.19B 9.63%
2016-09-30 $0.02B $0.22B 9.83%
2016-06-30 $0.02B $0.21B 10.76%
2016-03-31 $0.02B $0.21B 11.21%
2015-12-31 $0.02B $0.17B 11.73%
2015-09-30 $0.02B $0.19B 10.69%
2015-06-30 $0.02B $0.18B 10.47%
2015-03-31 $0.02B $0.18B 10.75%
2014-12-31 $0.02B $0.17B 11.11%
2014-09-30 $0.02B $0.16B 12.03%
2014-06-30 $0.01B $0.16B 9.09%
2014-03-31 $0.01B $0.15B 8.68%
2013-12-31 $0.01B $0.15B 8.89%
2013-09-30 $0.01B $0.15B 9.14%
2013-06-30 $0.02B $0.15B 12.90%
2013-03-31 $0.02B $0.14B 13.24%
2012-12-31 $0.02B $0.14B 13.58%
2012-09-30 $0.02B $0.14B 17.02%
2012-06-30 $0.02B $0.13B 16.70%
2012-03-31 $0.02B $0.13B 17.32%
2011-12-31 $0.02B $0.12B 17.80%
2011-09-30 $0.02B $0.12B 14.59%
2011-06-30 $0.02B $0.12B 15.08%
2011-03-31 $0.02B $0.11B 14.55%
2010-12-31 $0.02B $0.12B 14.08%
2010-09-30 $0.01B $0.11B 12.94%
2010-06-30 $0.01B $0.10B 12.40%
2010-03-31 $0.01B $0.10B 12.90%
2009-12-31 $0.01B $0.09B 13.30%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.516B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.25
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00